D-gluco-Heptonic acid, sodium salt (1:1), (2xi)-
CASRN#
31138-65-5, 2670-72-6
INCI Name
SODIUM GLUCEPTATE
Alternate Names
alpha-D-Glucoheptonic acid sodium salt; D-Gluco-heptonic acid, monosodium salt; D-glycero-D-guloHeptonic acid sodium salt; D-glycero-D-gulo-Heptonic acid, monosodium salt; Gluceptate Sodium; Glucoheptonic Acid Sodium Salt; Glucosecarboxylic Acid Sodium Sa
Common Trade Names
SEQLENE 540; SEQLENE ES-50; H-Quest L-50 LA; Milco 150
Molecular Weight
248 g/mol
Functional Uses
chelating agent
Common Impurities
-
Is this a VOC?
No
Is this an exempt VOC?
No
Vapor Pressure
1.2E-19 mm Hg
Octanol-water partition coefficient (log Kow)
-6.44
Solubility at 25 C
1E+6 mg/l
Boiling Point
117 °C
Particle size range as aerodynamic diameter
- - - μm
Hazard Summary
C2C Chemical Rating
c/b
GHS Health
H320
GHS Enviro
None
Assessed by
U.S. EPA Low Priority Chemical report.
Assessment Date
Jul 10, 2020
Assessment Expires
Jul 9, 2025
Verification Status
verified
Executive Summary
Sodium glucoheptonate belongs to the hydroxycarboxylic acid salt family. The chemical structure of sodium glucoheptonate consists of a seven-carbon chain with hydroxyl (-OH) groups terminating in a carboxylic acid group. The close proximity of the oxygen atoms within the chemical structure lends to its function as a highly efficient chelating agent, by binding to positively charged metal ions in solution and thereby prevent these ions from forming insoluble precipitates with other ions that may be present. Sodium glucoheptonate functions as a chelating agent over a wide pH range due to its efficiency in forming stable chelates with divalent and trivalent metal ions such as calcium, magnesium, iron, aluminum, and other metals, thereby reducing the adverse effects these metals can have on systems. These properties contribute to the use of sodium glucoheptonate as a high performing chelating agent in a variety of applications and product sectors. NOTE: The data provided in this assessment came primarily from the US EPA final designation report, Supporting Information for Low-Priority Substance D-gluco-Heptonic acid, sodium salt (1:1), (2.xi.)- (Sodium Glucoheptonate) (https://www.regulations.gov/document?D=EPA-HQ-OPPT-2019-0107-0010). According to US EPA, “low-priority substance designations give the public notice of chemical substances for which the hazard and/or exposure potential is anticipated to be low or nonexistent and provides some insight into which chemical substances are likely not to need additional evaluation and risk management under TSCA.”
Hazard Tables

How to read the GHS Hazard Summary Table

 
Carcinogenicity
Mutagenicity
Reproductive Toxicity
Developmental Toxicity
Acute Toxicity
STOT-Single
STOT-Repeated
STOT- Neurotoxicity-Single
STOT- Neurotoxicity-Repeated
Skin Sensitizer
Respiratory Sensitizer
Skin Corrosion/Irritation
Serious Eye Damage/Eye Irritation
Acute Aquatic Toxicity
Chronic Aquatic Toxicity
Ozone Depletion
Oral
Dermal
Inhalation
NC
Rationale
Available data is insufficient for GHS classification: sodium glucoheptonate’s transformation profile, lack of structural alerts in the parent chemical substance, modelled predictions of non-carcinogenicity, and experimental genotoxicity results provide sufficient information to indicate that this chemical has low concern for carcinogenicity.
NC
Rationale
Available data is insufficient for GHS classification: sodium glucoheptonate’s transformation profile, lack of structural alerts in the parent chemical substance, modelled predictions of non-carcinogenicity, and experimental genotoxicity results provide sufficient information to indicate that this chemical has low concern for carcinogenicity.
NC
Rationale
Available data is insufficient for GHS classification: sodium glucoheptonate’s transformation profile, lack of structural alerts in the parent chemical substance, modelled predictions of non-carcinogenicity, and experimental genotoxicity results provide sufficient information to indicate that this chemical has low concern for carcinogenicity.
NC
Rationale
Multiple studies provide sufficient evidence to indicate low concern for genotoxicity.
NC
Rationale
Lower confidence due to use of combined repeat dose, reproductive, developmental toxicity study. No reproductive effects were observed in an OECD 422 study which provides sufficient evidence to indicate low concern for reproductive toxicity.
CNP
Rationale
No data available.
CNP
Rationale
No data available.
NC
Rationale
Lower confidence due to use of combined repeat dose, reproductive, developmental toxicity study. No reproductive effects were observed in an OECD 422 study, and multiple analog studies, which provide sufficient evidence to indicate low concern for developmental toxicity.
CNP
Rationale
No data available.
CNP
Rationale
No data available.
NC
Rationale
This study provides sufficient evidence to indicate a low concern for acute oral toxicity.
NC
Rationale
This study provides sufficient evidence to indicate a low concern for acute dermal toxicity.
CNP
Rationale
Data not available.
CNP
Rationale
Data not available.
CNP
Rationale
Data not available.
CNP
Rationale
Data not available.
NC
Rationale
This study provides sufficient evidence to indicate a low concern for repeat dose oral toxicity.
CNP
Rationale
Data not available.
CNP
Rationale
Data not available.
NC
Rationale
Relevant endpoints measured in a OECD 422 repeat dose toxicity study provide sufficient information to indicate a low concern of neurotoxicity. Lower confidence due to no traditional neurotoxicity studies available.
CNP
Rationale
Data not available.
CNP
Rationale
Data not available.
NC
Rationale
Relevant endpoints measured in a OECD 422 repeat dose toxicity study provide sufficient information to indicate a low concern of neurotoxicity. Lower confidence due to no traditional neurotoxicity studies available.
CNP
Rationale
Data not available.
CNP
Rationale
Data not available.
NC
Rationale
An OECD Guideline 429 study provides sufficient information to indicate low concern for skin sensitization.
NC
Rationale
No structural alerts identified for respiratory sensitization. Lower confidence because a lack of structural alerts is insufficient for establishing a GHS classification.
NC
Rationale
Multiple studies provide sufficient evidence to indicate low concer for skin irritation. Lower confidence due to analog.
Cat 2B
Rationale
Multiple studies on analogs provides sufficient evidence to indicate moderate concern for eye irritation. Lower confidence due to analog.
NC
Rationale
Studies on aquatic vertebrates provides sufficient information to indicate low concern for acute exposure.
NC
Rationale
Predicted toxicity values from modelling provide sufficient evidence to indicate a low concern for chronic exposure to algae.
NC
Rationale
Chemical is not on Montreal Protocol or IPCC List.
Other
  • Explosives: Not classified
  • Flammable Gases: Not classified
  • Aerosols: Not classified
  • Oxidizing Gases: Not classified
  • Flammable Liquids: Not classified
  • Flammable Solids: Not classified
  • Self-reactive substances and mixtures: Not classified
  • Pyrophoric Liquids: Not classified
  • Pyrophoric Solids: Not classified
  • Self-heating Substances and Mixtures: Not classified
  • Substances and Mixtures which in contact with water, emit flammable gases: Not classified
  • Oxidizing Liquids: Not classified
  • Oxidizing Solids: Not classified
  • Organic Peroxides: Not classified
  • Corrosive to Metals: Not classified
  • Desensitized Explosives: Not classified

How to read the C2CC Hazard Summary Table

Human Health
Environmental
Other
 
Carcinogenicity
Mutagenicity
Reproductive & Developmental Toxicity
Endocrine Activity / Disruption
Oral Toxicity
Dermal Toxicity
Inhalation Toxicity
Neurotoxicity
Skin, Eye, and Respiratory Corrosion/Irritation
Sensitization of Skin and Airways
Fish Toxicity
Daphnia Toxicity
Algae Toxicity
Terrestrial Toxicity
Persistence
Bioaccumulation
Climatic Relevance
Other (Human Health)
Organohalogens
Toxic Metals
Other (Environmental Health)
Oral
Dermal
Inhalation
-
-
-
G
G
-
-
-
Rationale
No data available.
G
G
-
G
-
-
Y
G
G
G
G
-
G
Rationale
Available biodegradation studies provide sufficient evidence of low concern for persistence.
G
Rationale
Based on the estimated bioaccumulation factor (BAF) value of 3.16 using the Estimation Programs Interface (EPI) Suite models, EPA has sufficient information that sodium glucoheptonate has low potential for bioaccumulation in the environment based on the low-concern benchmark of less than 1000.
Y
G
Rationale
No additional data available.
G
G
G
Rationale
No additional data available.